[DPHARMA] QoQ Cumulative Quarter Result on 30-Jun-2020 [#2]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
13-Aug-2020
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2020
Quarter
30-Jun-2020 [#2]
Profit Trend
QoQ- 108.61%
YoY- -0.32%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Cumulative Result
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Revenue 166,454 569,902 435,816 302,044 158,713 576,462 438,707 -47.55%
PBT 23,176 76,157 55,686 37,118 17,727 70,809 56,870 -45.00%
Tax -5,562 -17,547 -13,269 -8,828 -4,166 -15,536 -13,630 -44.95%
NP 17,614 58,610 42,417 28,290 13,561 55,273 43,240 -45.01%
-
NP to SH 17,614 58,610 42,417 28,290 13,561 55,273 43,240 -45.01%
-
Tax Rate 24.00% 23.04% 23.83% 23.78% 23.50% 21.94% 23.97% -
Total Cost 148,840 511,292 393,399 273,754 145,152 521,189 395,467 -47.84%
-
Net Worth 635,424 642,484 584,565 581,725 540,662 525,364 505,919 16.39%
Dividend
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Div - 45,891 3,479 3,421 - 40,937 6,745 -
Div Payout % - 78.30% 8.20% 12.10% - 74.06% 15.60% -
Equity
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Net Worth 635,424 642,484 584,565 581,725 540,662 525,364 505,919 16.39%
NOSH 706,026 706,026 706,026 684,383 684,383 684,383 680,106 2.52%
Ratio Analysis
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
NP Margin 10.58% 10.28% 9.73% 9.37% 8.54% 9.59% 9.86% -
ROE 2.77% 9.12% 7.26% 4.86% 2.51% 10.52% 8.55% -
Per Share
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
RPS 23.58 80.72 62.63 44.13 23.19 84.49 65.04 -49.12%
EPS 2.49 8.46 6.16 4.13 1.98 8.25 6.49 -47.16%
DPS 0.00 6.50 0.50 0.50 0.00 6.00 1.00 -
NAPS 0.90 0.91 0.84 0.85 0.79 0.77 0.75 12.91%
Adjusted Per Share Value based on latest NOSH - 684,383
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
RPS 17.30 59.24 45.31 31.40 16.50 59.93 45.61 -47.56%
EPS 1.83 6.09 4.41 2.94 1.41 5.75 4.50 -45.08%
DPS 0.00 4.77 0.36 0.36 0.00 4.26 0.70 -
NAPS 0.6606 0.6679 0.6077 0.6047 0.5621 0.5461 0.5259 16.40%
Price Multiplier on Financial Quarter End Date
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Date 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 -
Price 2.75 3.38 3.16 1.62 1.39 1.42 1.40 -
P/RPS 11.66 4.19 5.05 3.67 5.99 1.68 2.15 208.36%
P/EPS 110.23 40.72 51.84 39.19 70.15 17.53 21.84 193.94%
EY 0.91 2.46 1.93 2.55 1.43 5.70 4.58 -65.91%
DY 0.00 1.92 0.16 0.31 0.00 4.23 0.71 -
P/NAPS 3.06 3.71 3.76 1.91 1.76 1.84 1.87 38.82%
Price Multiplier on Announcement Date
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Date 03/05/21 22/02/21 12/11/20 13/08/20 18/05/20 13/02/20 29/11/19 -
Price 2.93 3.42 4.04 3.15 1.72 1.64 1.39 -
P/RPS 12.43 4.24 6.45 7.14 7.42 1.94 2.14 222.78%
P/EPS 117.44 41.20 66.28 76.20 86.80 20.24 21.68 208.12%
EY 0.85 2.43 1.51 1.31 1.15 4.94 4.61 -67.57%
DY 0.00 1.90 0.12 0.16 0.00 3.66 0.72 -
P/NAPS 3.26 3.76 4.81 3.71 2.18 2.13 1.85 45.84%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment